secwatch.observer — SEC 8-K summary
======================================

Issuer:     Korro Bio, Inc. (KRRO)
CIK:        0001703647
Form:       8-K
Filed at:   2025-03-27T23:59:59+00:00
Accession:  0001193125-25-064792
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Korro Bio CFO Vineet Agarwal returns from medical leave; Oliver Dolan named principal accounting officer
--------------------------------------------------------------------------------

- CFO Vineet Agarwal reappointed as principal financial officer effective March 27, ending temporary medical leave since Feb 11.
- CEO Ram Aiyar ceases interim CFO duties; remains President and CEO.
- Oliver Dolan, SVP Finance, appointed principal accounting officer; granted 20,000-share stock option at closing price.
- Option grant effective April 1, 2025; standard indemnification agreement entered.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1703647/000119312525064792/0001193125-25-064792-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1703647/000119312525064792/d937220d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-064792

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer